Granted Patent
B2
US 8,912,205 · App. 13/943,049 · Granted Dec 16, 2014
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
Inventors:
Malcolm Clive Carter (Stevenage, GB); George Stuart Cockerill (Stevenage, GB); Karen Elizabeth Lackey (Durham, NC)
Assignee:
GlaxoSmithKline LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A pharmaceutical formulation comprising the compound of formula
Claims (5)
1. A pharmaceutical formulation presented in unit dose form comprising
the compound of formula
as an active ingredient,
wherein said active ingredient s present within said unit dose form in an amount from 70 mg to 700 mg.
2. The formulation of claim 1 , wherein said unit dose is a tablet.
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 3, 2015
From: LEO OSPREY LIMITED
To: NOVARTIS AG
Reel/Frame 035771/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 2, 2015
From: GLAXOSMITHKLINE LLC
To: LEO OSPREY LIMITED
Reel/Frame 035762/0741 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 13394049 PREVIOUSLY RECORDED ON REEL 031739 FRAME 0287. ASSIGNOR(S) HEREBY CONFIRMS THE APPLICATION NUMBER SHOULD READ 13943049.
Recorded Dec 17, 2013
From: LACKEY, KAREN ELIZABETH; CARTER, MALCOLM CLIVE; COCKERILL, GEORGE STUART
To: GLAXOSMITHKLINE LLC
Reel/Frame 031831/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 9, 2013
From: LACKEY, KAREN ELIZABETH; CARTER, MALCOLM CLIVE; COCKERILL, GEORGE STUART
To: GLAXOSMITHKLINE LLC
Reel/Frame 031739/0287 →
Priority Claims (1)
GB 9800569
· Jan 12, 1998
· national
Continuity (5)
Continuation
09582746